Gregori
Damia Gregori, Villeurbanne FR
| Patent application number | Description | Published |
|---|---|---|
| 20160040353 | METHOD FOR DEPOSITING A PHOTOCATALYTIC COATING AND RELATED COATINGS, TEXTILE MATERIALS AND USE IN PHOTOCATALYSIS - A method for depositing a photocatalytic coating on a support, the method having the steps: a) providing an aqueous and/or alcoholic suspension of nanoparticles of a semiconducting material, b) providing a sol in an aqueous and/or alcoholic solution of a hydrolyzed organosilane, c) mixing the suspension and the sol and proceeding with deposition of the obtained mixture on the support to be covered, d) performing a drying operation, e) and optionally producing an illumination of the obtained coating after drying at one wavelength at least causing activation of the semiconducting material, so as to remove at least 3% of the organic groups initially present in the coating and bound to the silicon atoms through a Si—C bond; as well as coatings with photocatalytic properties, materials, notably textiles, covered with such a coating and the use of such coatings and materials for photocatalysis. | 02-11-2016 |
Eric Gregori, Lindenhurst, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100238117 | Movable Barrier Operator System Display Method and Apparatus - A movable barrier operator system operational component includes an integral display comprising at least one of a numeric display, an alphanumeric display, and a graphics display. The display can comprise an active display or an active interactive display and can further operate in conjunction with adjacent user-input interface opportunities. So configured, numerous user interface events can be highly leveraged to contribute to ease of installation and ease and reliability of use. | 09-23-2010 |
| 20130170639 | Transmission of Data Including Conversion of Ternary Data to Binary Data - Binary data relating to a movable barrier operator is converted to ternary data. The ternary data is converted into corresponding binary information in a way not mirroring the first conversion method. In one approach, this second conversion converts each ternary trit into a corresponding binary pair. Initial binary bits correspond to, for example, fixed and/or non-fixed information. | 07-04-2013 |
Eric M. Gregori, Lindenhurst, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20110317835 | Method and Apparatus to Facilitate Wireline Transmission of an Encrypted Rolling Code - An encrypted rolling code ( | 12-29-2011 |
Fabrice Gregori, Fontenay Aux Roses FR
| Patent application number | Description | Published |
|---|---|---|
| 20120283935 | Method for Informng the Driver of a Vehicle Provided with a System for Automatically Stopping and Restarting the Engine in the Event an Automatic Stop is Unavailable - The invention relates to a method for informing, in a reassuring manner, the driver of a vehicle that is provided with a heat engine and a STT System for automatically stopping and restarting the engine. The method comprises the following steps: verifying that the driver requested the automatic engine stop; determining that the vehicle System does or does not allow the automatic stop; and if the automatic stop was properly requested and the vehicle System does not allow the automatic stop, informing the driver that not automatically stopping the engine is a normal operation. | 11-08-2012 |
Giovanni Gregori, Coral Gables, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20100208201 | ENHANCED OPTICAL COHERENCE TOMOGRAPHY FOR ANATOMICAL MAPPING - A system, method and apparatus for anatomical mapping utilizing optical coherence tomography. In the present invention, 3-dimensional fundus intensity imagery can be acquired from a scanning of light back-reflected from an eye. The scanning can include spectral domain scanning, as an example. A fundus intensity image can be acquired in real-time. The 3-dimensional data set can be reduced to generate an anatomical mapping, such as an edema mapping and a thickness mapping. Optionally, a partial fundus intensity image can be produced from the scanning of the eye to generate an en face view of the retinal structure of the eye without first requiring a full segmentation of the 3-D data set. Advantageously, the system, method and apparatus of the present invention can provide quantitative three-dimensional information about the spatial location and extent of macular edema and other pathologies. This three-dimensional information can be used to determine the need for treatment, monitor the effectiveness of treatment and identify the return of fluid that may signal the need for re-treatment. | 08-19-2010 |
| 20110273667 | ENHANCED OPTICAL COHERENCE TOMOGRAPHY FOR ANATOMICAL MAPPING - A system, method and apparatus for anatomical mapping utilizing optical coherence tomography. In the present invention, 3-dimensional fundus intensity imagery can be acquired from a scanning of light back-reflected from an eye. The scanning can include spectral domain scanning, as an example. A fundus intensity image can be acquired in real-time. The 3-dimensional data set can be reduced to generate an anatomical mapping, such as an edema mapping and a thickness mapping. Optionally, a partial fundus intensity image can be produced from the scanning of the eye to generate an en face view of the retinal structure of the eye without first requiring a full segmentation of the 3-D data set. Advantageously, the system, method and apparatus of the present invention can provide quantitative three-dimensional information about the spatial location and extent of macular edema and other pathologies. This three-dimensional information can be used to determine the need for treatment, monitor the effectiveness of treatment and identify the return of fluid that may signal the need for re-treatment. | 11-10-2011 |
Giovanni Gregori, Roma IT
| Patent application number | Description | Published |
|---|---|---|
| 20140107945 | METHOD FOR THE DYNAMIC QUANTITATIVE CHARACTERIZATION OF THE AGEING OF SOLID MATERIALS - A method, starting from acoustic emission signals of a material under examination, for determining parameters dynamically characterizing an ageing state of a material is described. The method focuses on solid material properties that are widely sub-microscopic and as such are non-observable by any other known experimental method. | 04-17-2014 |
Jason Gregori, Petaluma, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20130013589 | Customer Relationship Management System - A computer-implemented method for customer relationship management is provided. The method may include receiving an indication from a user at one or more customer relationship management graphical user interfaces. The method may further include identifying one or more accounts associated with the user. The method may also include providing an itinerary or portion of an itinerary to the user for a particular time period via at least one of the one or more customer relationship management graphical user interfaces. The method may additionally include filtering the one or more accounts based upon, at least in part, an input from the user to generate a filtered result set. The method may also include storing at least one of the filtered result set and the itinerary. | 01-10-2013 |
Luca Gregori, Padova IT
| Patent application number | Description | Published |
|---|---|---|
| 20090264680 | Process for the synthesis and purification of (4-methoxybutyl) (4-trifluoromethylphenyl) methanone - A process for the preparation of 4-trifluoromethylvalerophenone is described. The process described is a three step process comprising the synthesis of organomagnesium specie, coupling reaction between the organomagnesium specie and trifluoromethylbenzonitrile or trifluoromethylbenzoyl chloride and preferably a purification of the product obtained in suitable reaction conditions. In the process an extraction phase of the final product is not required. | 10-22-2009 |
Luisa Gregori, Baltimore, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090068640 | METHODS FOR DETECTING AND INACTIVATING A PRION - A method for the isolation or detection of a prion in a sample is disclosed. Also disclosed are methods for the disinfection and/or decontamination and/or inactivation of TSE infectivity. | 03-12-2009 |
Manuel Gregori, Meldola (fc) IT
| Patent application number | Description | Published |
|---|---|---|
| 20130324769 | Method for manufacturing perfluorovinylethers - The invention pertains to a process for the manufacture of a perfluorovinylether by hydrodehalogenation of a halofluoroether (HFE) having general formula (I-A) or (I-B): | 12-05-2013 |
Massimo Gregori, Tradate IT
| Patent application number | Description | Published |
|---|---|---|
| 20120006477 | METHOD FOR MAKING HOLLOW STIFFENING ELEMENTS - A method for making hollow stiffening elements with co-curing technique on a structure made of composite material | 01-12-2012 |
Silvia Gregori, Buccinasco (mi) IT
| Patent application number | Description | Published |
|---|---|---|
| 20150132272 | COMPOSITIONS AND METHODS FOR DIMINISHING AN IMMUNE RESPONSE - The invention is based upon the discovery that T regulatory type 1 (Tr1) cells express particular cell surface markers that allow for their selection, enrichment, isolation, purification and administration. The ability to use the particular markers described herein to select, enrich, isolate, purity and administer Tr1 cells allows for improved methods of Tr1 therapies for treating a wide variety of diseases and disorders. | 05-14-2015 |
Silvia Adriana Gregori, Basel CH
| Patent application number | Description | Published |
|---|---|---|
| 20100183602 | Induction of Tolerogenic Phenotype in Mature Dendritic Cells - The present invention relates to the use of a CD45 binding molecule to modulate the function of Dendritic cells. In particular the present invention relates to the use of a CD45 binding molecule to induce tolerogenic dendritic cells, useful in the treatment of diseases or disorders such as autoimmune diseases, transplant rejection. | 07-22-2010 |
Silvia Adriana Gregori, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20100041145 | TOLEROGENIC DENDRITIC CELLS, METHOD FOR THEIR PRODUCTION AND USES THEROF - The present invention relates to a tolerogenic dendritic cell population (Tr-DC) capable of generating a population of T cells having regulatory activity, method of production and uses thereof. Furthermore, soluble HLA-G promotes the differentiation of a population of T cells with regulatory activity. | 02-18-2010 |
Timothy R. Gregori, Lockport, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090298304 | Co-Edge Connector - A connector includes a housing with a set of broad-side coupled terminals configured to engage a pair of signal traces on a first panel and a second panel and transfer signals between the signal traces on the first and second panels. The connector may be slid onto the edges and then fastened to one or both of the panels with a locking feature. Multiple signal pairs may be included in the connector and may be electrically separated. The design of the connector helps facilitate high-speed data communication per signal pair with a return loss performance that does not exceed at predetermined level. Certain configurations of the connector may be used for co-planar configurations. Certain configurations of the connector may couple together panels of different thicknesses. | 12-03-2009 |
| 20110053425 | CO-EDGE CONNECTOR - A connector includes a housing with a set of broad-side coupled terminals configured to engage a pair of signal traces on a first panel and a second panel and transfer signals between the signal traces on the first and second panels. The connector may be slid onto the edges and then fastened to one or both of the panels with a locking feature. Multiple signal pairs may be included in the connector and may be electrically separated. The design of the connector helps facilitate high-speed data communication per signal pair with a return loss performance that does not exceed at predetermined level. Certain configurations of the connector may be used for co-planar configurations. Certain configurations of the connector may couple together panels of different thicknesses. | 03-03-2011 |
| 20120040565 | CO-EDGE CONNECTOR - A co-edge connector ( | 02-16-2012 |
| 20130084716 | SYSTEM AND CONNECTOR CONFIGURED FOR MACRO MOTION - A connector system is configured for macro motion. Two mating terminals are configured so that during macro motion cycles, the resistance between two terminals does not substantially increase. One terminal can have multiple, somewhat spherical-shaped mating surfaces while a mating surface on the other terminal can be flat. The mating terminals can be configured to provide desirable resistance performance after more than 5000 cycles of macro motion. | 04-04-2013 |
Wolfgang Gregori, Ludwigshafen DE
| Patent application number | Description | Published |
|---|---|---|
| 20110201502 | Crystalline Complexes of Pendimethalin and Metazachlor - The present invention relates to crystalline complexes of pendimethalin and metazachlor. It also relates to agriculturally useful compositions of the complexes. | 08-18-2011 |
| 20120149577 | Aqueous Suspension Concentrate Formulations Containing Saflufenacil - The present invention relates to aqueous suspension concentrate formulation for plant protection comprising: | 06-14-2012 |
| 20120157312 | Aqueous Concentrate Formulations Containing Saflufenacil and Glyphosate - The present invention relates to aqueous concentrate formulations for plant protection comprising: | 06-21-2012 |
| 20120231954 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL AND GLYPHOSATE - The present invention relates to liquid suspension concentrate formulations for plant protection comprising: 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethy)amino]sulfonyl]benzamide in the form of the anhydrate; N-(phosphonomethyl)glycine in the form of its free acid, in the form of the ammonium salt or a substituted ammonium salt or a mixture thereof; at least one diluent selected from: hydrocarbon solvents having a boiling point of at least 100° C.; and —C | 09-13-2012 |
| 20120302444 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL - The present invention relates to liquid suspension concentrate formulations for plant protection comprising: 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide in the form of the crystalline anhydrate; at least one diluent selected from: hydrocarbon solvents having a boiling point of at least 100° C.; and C | 11-29-2012 |